文献速递炎症性肠病消化内镜

炎症性肠病患者结肠镜检查中丙泊酚与咪达唑仑联合芬太尼镇静的患者满意度比较

Patient Satisfaction of Propofol Versus Midazolam and Fentanyl Sedation During Colonoscopy in Inflammatory Bowel Disease.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-10-22

这项随机临床试验比较了护士给予丙泊酚深度镇静(NAPS,n=63)与咪达唑仑联合芬太尼中度镇静(n=67)在炎症性肠病患者结肠镜检查中的效果。主要终点为出院时患者满意度,采用13项5点Likert量表(13-65分)评估。深度镇静组满意度评分显著高于中度镇静组(平均60.1,SD 3.4 vs 51.2,SD 8.4;P < .001),且更愿意未来接受相同镇静方式及更频繁的结肠镜检查。NAPS无安全性信号。

要点

  • 炎症性肠病患者结肠镜检查中,丙泊酚深度镇静的满意度显著高于咪达唑仑联合芬太尼中度镇静。
  • 深度镇静组患者更愿意未来接受相同镇静方式并接受更频繁的结肠镜检查。
  • NAPS无安全性信号,但需注意护士给予丙泊酚的资质与监测要求。

核心结论

  • 炎症性肠病患者更倾向于选择丙泊酚深度镇静而非咪达唑仑联合芬太尼中度镇静。
  • 提供NAPS可能有助于提高患者对内镜监测方案的依从性。

研究设计与样本

  • 随机临床试验,比较NAPS深度镇静(n=63)与咪达唑仑联合芬太尼中度镇静(n=67)。
  • 主要终点为出院时患者满意度,采用13项5点Likert量表(13-65分)评估。

主要发现

  • 深度镇静组满意度评分显著高于中度镇静组(平均60.1,SD 3.4 vs 51.2,SD 8.4;P < .001)。
  • 满意度差异主要源于疼痛更少、遗忘更多、镇静方式更符合喜好以及本次体验优于既往。
  • 深度镇静组患者更常偏好未来结肠镜检查使用相同镇静方式,并倾向于接受更频繁的结肠镜检查。
  • 中度镇静组需要另一名结肠镜医师协助及因疼痛中断操作的发生率显著更高。
  • NAPS未发现安全性信号。

关键数值与推荐

  • 满意度问卷共13项,每项5点Likert评分,总分13-65分,分数越高表示结果越积极。
  • 深度镇静组满意度平均60.1(SD 3.4),中度镇静组平均51.2(SD 8.4),P < .001。

临床怎么用

  • 对于接受结肠镜检查的炎症性肠病患者,可考虑使用护士给予丙泊酚深度镇静以提高满意度和未来检查依从性。
  • 需确保具备护士给予丙泊酚的资质、监测条件和处理不良反应的能力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Colonoscopy is essential for optimal management of inflammatory bowel disease. However, many patients opt out due to unpleasantness related to this procedure. We investigated if Nurse Administered Propofol Sedation (NAPS) would improve patient satisfaction and attitude towards future colonoscopies. METHODS: Randomized clinical trial of deep sedation with NAPS (n = 63) versus moderate midazolam and fentanyl sedation (n = 67). To assess the primary end point of patient satisfaction at discharge, we developed a Satisfaction Questionnaire comprising 13 items each rated by a 5-point Likert scale and with higher scores reflecting more positive outcomes (13-65 points). RESULTS: Fifty-six patients (43%) with ulcerative colitis, 48 (37%) with Crohn's disease, and 26 (20%) with high suspicion of inflammatory bowel disease were included. Most (88%) had previously had a colonoscopy and pre-procedure expectations were similar between groups. Patients receiving deep sedation had significantly higher satisfaction score (mean 60.1, SD 3.4) than those receiving moderate sedation (51.2, 8.4; P < .001). This was driven especially by less pain, more amnesia, sedation more to their liking, and better experience with the current than previous sedations. Importantly, these patients significantly more often preferred the same sedation for a future colonoscopy and were also inclined to accept more frequent colonoscopies. Assistance from another colonoscopist and disruption of the procedure due to pain occurred significantly more frequent in the moderate sedation group. There were no safety signals associated with NAPS. CONCLUSIONS: Patients with inflammatory bowel disease favor deep propofol sedation over moderate midazolam and fentanyl sedation. Availability of NAPS may facilitate patient adherence to endoscopy-based monitoring programs. Clinicaltrials.gov NCT01934088.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Steenholdt C, Jensen JT, Brynskov J, et al. Patient Satisfaction of Propofol Versus Midazolam and Fentanyl Sedation During Colonoscopy in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2020. PMID: 33371995. doi:10.1016/j.cgh.2020.10.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。